ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105014 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105014; 2) Community: the network communities that were significantly associated with the response to NSC 105014; 3) Molecule: the relationships between components within communities and NSC 105014; 4) MDR: the compounds that were significantly associated with the NSC 105014.

NSC Compound Enrichment Correlation
NSC 683557 Camptothecin Derivative 0.000135256398432181 0.57994801
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.000135256398432181 0.26925568
NSC 76356 Adenine, 9-.beta.-D-arabinofuranosyl-2-chloro- (8CI) 0.000135256398432181 0.8332045
NSC 95099 Bigitalin 0.000135256398432181 0.29215678
NSC 284751 Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate) 0.000216242727122389 0.46396375
NSC 606172 Camptothecin Derivative 0.000216242727122389 0.50433989
NSC 735037 Camptothecin Derivative 0.000216242727122389 0.58288095
NSC 638436 Null 0.000281397700245217 0.1926739
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.000281397700245217 0.42688708
NSC 750148 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline 0.000285499812229894 -0.15914526
Total:75  Current:1    [First] [Prev] [Next] [Last]